Ontario study aims to match pancreatic cancer patients with tailored treatments
NCT ID NCT05927298
First seen Feb 23, 2026 · Last updated Jun 13, 2026 · Updated 19 times
Summary
This study enrolls 200 people with pancreatic cancer to collect tumor tissue, blood, and stool samples. Researchers will analyze the genetic makeup of each tumor and grow mini-tumors in the lab to test which drugs work best. The goal is to see if this personalized approach can help more patients receive treatments matched to their specific cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREAS CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Princess Margaret Cancer Centre
Toronto, Ontario, M5G 2M9, Canada
Conditions
Explore the condition pages connected to this study.